Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GS vs MRNA✓SelectedUSD · MRNAGS vs MRNA performance historyLatest closeAs of-1.57%11/17
Stock and ETF performance explorer

GS vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+176.6%
MRNA return
+168.0%
Excess return
+8.5%
Maximum drawdown
-30.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.6%-3.9%+2.4%-1.4%
7D-3.6%-17.6%+14.0%-3.0%
30D-0.4%-5.1%+4.7%-0.3%
3M-16.1%+220.8%-236.9%-20.4%
6M-6.6%+321.7%-328.3%-14.9%
YTD+1.3%+601.3%-600.0%-14.1%
1Y+15.4%+735.2%-719.8%-4.5%
3Y+176.6%+170.5%+6.1%+123.3%
All+176.6%+168.0%+8.5%+123.3%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling